Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Nov-Dec;19(6):333-9.
doi: 10.1177/153331750401900607.

Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients

Rita Moretti  1 , Paola Torre, Rodolfo M Antonello, Tatiana Cattaruzza, Giuseppe Cazzato
Affiliations
Clinical Trial

Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients

Rita Moretti et al. Am J Alzheimers Dis Other Demen. 2004 Nov-Dec.

Abstract

The goal of this study was to determine whether rivastigmine, a dual inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), has any effect on delirium in vascular dementia (VaD). The results from this follow-up study suggest that although delirium is frequent in elderly, cognitively impaired patients, it might not be a simple consequence of acute disease and hospitalization. Rather, delirium can be secondary to brain damage and to metabolic disturbances. According to the Lewy body dementia model, delirium could be induced by a lack of acetylcholine in the brain. Rivastigmine may help reduce the frequency of delirium episodes and help shorten their duration. Additional studies are required to better define the causes of delirium, which currently has no definitive treatment.

PubMed Disclaimer

References

    1. Bourdel-Marchasson I, Vincent S, Germain C, et al.: Delirium symptoms and low dietary intake in older inpatients are independent predictors of institutionalization: A 1-year prospective populationbased study. J Gerontol A Biol Sci Med Sci.2004; 59(4): 350-354. - PubMed
    1. Trzepacz PT: Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord.1999; 10(5): 330-334. - PubMed
    1. Miller BL, Josephson A: Cognitive manifestations of metabolic brain disease. American Academy of Neurology, 2003 Honolulu [lecture]. 5PC.005-5: 1-10.
    1. Rochat S, Camus V, Bula C: Acute confusional state in the elderly. Rev Med Suisse Romande.2003; 123(11): 685-689. - PubMed
    1. Torpy JM, Lynm C, Glass RM: JAMA patient page. Dementia. JAMA.2004; 292(12): 1514-1514. - PubMed

Publication types